ASSEMBLY BIOSCIENCES, INC. Income Statement
ASMB|1 years of annual SEC 10-K data (FY2025-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data. All figures from audited SEC 10-K filings.
ASSEMBLY BIOSCIENCES, INC. reported $72M in revenue and $6M in net loss for FY2025. Its profit margin was -8.5% in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -0.32 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 |
|---|---|
| Revenue | $72.3M |
| SG&A Expense | $19.6M |
| R&D Expense | $64.8M |
| Operating Income | -$12.1M |
| Income Tax | $0 |
| Net Income | -$6.1M |
| EPS (Basic) | -$6.69 |
| EPS (Diluted) | -$6.69 |
| Shares Outstanding | 7.5M |
| Operating Margin | -16.8% |
| Profit Margin | -8.5% |